Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Combination of this class of drugs with Revuforj is not recommended; if co-admin···【more】
Release date：2026-01-28Recommended：321
Remission is the primary treatment goal for acute myeloid leukemia (AML) and acu···【more】
Release date：2026-01-28Recommended：382
Administration of rivoceranib is continued until disease progression, occurrence···【more】
Release date：2026-01-28Recommended：374
The recommended dosage of Revuforj varies according to the patient's body we···【more】
Release date：2026-01-28Recommended：337
Take Revuforj exactly as directed by your healthcare provider. Do not change you···【more】
Release date：2026-01-28Recommended：354
Your doctor may prescribe Revuforj tablets in multiple dosage strengths, and it ···【more】
Release date：2026-01-28Recommended：299
Revumenib is a menin inhibitor that blocks the interaction between wild-type lys···【more】
Release date：2026-01-28Recommended：336
Revuforj tablets are available in different dosage strengths, each corresponding···【more】
Release date：2026-01-28Recommended：442
Revuforj is typically indicated for the treatment of patients with specific type···【more】
Release date：2026-01-28Recommended：365
On June 24, 2025, Syndax Pharmaceuticals announced that the U.S. Food and Drug A···【more】
Release date：2026-01-28Recommended：340
Acute lymphoblastic leukemia (ALL) is a hematologic malignancy originating from ···【more】
Release date：2026-01-28Recommended：393
Recently, Syndax Pharmaceuticals announced additional positive data from the AUG···【more】
Release date：2026-01-28Recommended：328
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
